Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A. Herrmann E, et al. Among authors: stockle m. J Urol. 2010 Feb;183(2):460-6. doi: 10.1016/j.juro.2009.10.026. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006851
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study.
Steffens S, Janssen M, Roos FC, Becker F, Schumacher S, Seidel C, Wegener G, Thüroff JW, Hofmann R, Stöckle M, Siemer S, Schrader M, Hartmann A, Kuczyk MA, Junker K, Schrader AJ. Steffens S, et al. Among authors: stockle m. Eur J Cancer. 2012 Oct;48(15):2347-52. doi: 10.1016/j.ejca.2012.05.002. Epub 2012 Jun 13. Eur J Cancer. 2012. PMID: 22698386
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.
Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A; German Network Of Kidney Cancer. Polifka I, et al. Among authors: stockle m. Hum Pathol. 2019 Jan;83:212-223. doi: 10.1016/j.humpath.2018.08.006. Epub 2018 Aug 17. Hum Pathol. 2019. PMID: 30121370
cMET: a prognostic marker in papillary renal cell carcinoma?
Erlmeier F, Bruecher B, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Mondorf Y, Ivanyi P, Mikuteit M, Steffens S; German Network Of Kidney Cancer. Erlmeier F, et al. Among authors: stockle m. Hum Pathol. 2022 Mar;121:1-10. doi: 10.1016/j.humpath.2021.12.007. Epub 2022 Jan 6. Hum Pathol. 2022. PMID: 34998840
The prognostic impact of Claudin 6 in papillary renal cell carcinoma.
Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F. Mikuteit M, et al. Among authors: stockle m. Pathol Res Pract. 2022 Mar;231:153802. doi: 10.1016/j.prp.2022.153802. Epub 2022 Feb 11. Pathol Res Pract. 2022. PMID: 35180650
Outcome of renal tumors in young adults.
Siemer S, Hack M, Lehmann J, Becker F, Stöckle M. Siemer S, et al. Among authors: stockle m. J Urol. 2006 Apr;175(4):1240-3; discussion 1243-4. doi: 10.1016/S0022-5347(05)00696-8. J Urol. 2006. PMID: 16515969
494 results